|
AMD
|
Technology |
Wedbush |
Maintains
|
Outperform
→
Outperform
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
AMD
|
Technology |
KeyBanc Capital Markets |
Maintains
|
Overweight
→
Overweight
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
AMD
|
Technology |
Benchmark |
Maintains
|
Buy
→
Buy
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
AMD
|
Technology |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
AMD
|
Technology |
Evercore ISI |
Maintains
|
Outperform
→
Outperform
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
AMD
|
Technology |
Rosenblatt |
Maintains
|
Buy
→
Buy
|
—
|
$732.2B
|
$242.11
|
-11.2%
|
-17.3%
|
-3.8%
|
+8.3%
|
+3.6%
|
-1.1%
|
|
KO
|
Consumer Defensive |
Jefferies |
Maintains
|
Buy
→
Buy
|
—
|
$353.3B
|
$76.89
|
+0.5%
|
+0.6%
|
+1.5%
|
+0.7%
|
-1.3%
|
-1.5%
|
|
AMAT
|
Technology |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$344.9B
|
$318.67
|
+1.7%
|
-6.6%
|
+2.1%
|
+6.1%
|
+2.5%
|
-0.5%
|
|
MRK
|
Healthcare |
Citigroup |
Maintains
|
Neutral
→
Neutral
|
—
|
$286.5B
|
$115.84
|
+0.9%
|
+2.1%
|
+1.2%
|
+1.8%
|
-3.5%
|
-0.4%
|
|
MRK
|
Healthcare |
Wells Fargo |
Maintains
|
Overweight
→
Overweight
|
—
|
$286.5B
|
$115.84
|
+0.9%
|
+2.1%
|
+1.2%
|
+1.8%
|
-3.5%
|
-0.4%
|
|
MRK
|
Healthcare |
Cantor Fitzgerald |
Maintains
|
Neutral
→
Neutral
|
—
|
$286.5B
|
$115.84
|
+0.9%
|
+2.1%
|
+1.2%
|
+1.8%
|
-3.5%
|
-0.4%
|
|
PEP
|
Consumer Defensive |
Wells Fargo |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$206.5B
|
$162.85
|
+1.3%
|
+2.0%
|
+0.8%
|
+1.8%
|
-2.4%
|
+0.3%
|
|
PEP
|
Consumer Defensive |
JP Morgan |
Maintains
|
Overweight
→
Overweight
|
—
|
$206.5B
|
$162.85
|
+1.3%
|
+2.0%
|
+0.8%
|
+1.8%
|
-2.4%
|
+0.3%
|
|
PEP
|
Consumer Defensive |
Citigroup |
Maintains
|
Buy
→
Buy
|
—
|
$206.5B
|
$162.85
|
+1.3%
|
+2.0%
|
+0.8%
|
+1.8%
|
-2.4%
|
+0.3%
|
|
AMGN
|
Healthcare |
Cantor Fitzgerald |
Maintains
|
Neutral
→
Neutral
|
—
|
$179.7B
|
$338.59
|
+4.0%
|
+8.2%
|
+0.4%
|
+4.5%
|
-2.2%
|
-3.0%
|
|
AMGN
|
Healthcare |
Leerink Partners |
Maintains
|
Outperform
→
Outperform
|
—
|
$179.7B
|
$338.59
|
+4.0%
|
+8.2%
|
+0.4%
|
+4.5%
|
-2.2%
|
-3.0%
|
|
AMGN
|
Healthcare |
Citigroup |
Maintains
|
Neutral
→
Neutral
|
—
|
$179.7B
|
$338.59
|
+4.0%
|
+8.2%
|
+0.4%
|
+4.5%
|
-2.2%
|
-3.0%
|
|
AMGN
|
Healthcare |
Morgan Stanley |
Maintains
|
Equal Weight
→
Equal Weight
|
—
|
$179.7B
|
$338.59
|
+4.0%
|
+8.2%
|
+0.4%
|
+4.5%
|
-2.2%
|
-3.0%
|
|
WDC
|
Technology |
Goldman Sachs |
Maintains
|
Neutral
→
Neutral
|
—
|
$163.6B
|
$290.24
|
-1.7%
|
-7.2%
|
-3.4%
|
+8.6%
|
+1.2%
|
-8.2%
|
|
WDC
|
Technology |
Cantor Fitzgerald |
Maintains
|
Overweight
→
Overweight
|
—
|
$163.6B
|
$290.24
|
-1.7%
|
-7.2%
|
-3.4%
|
+8.6%
|
+1.2%
|
-8.2%
|